Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China.
Concerning outlook with weak fundamentals.
Share Price & News
How has Concord Medical Services Holdings's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: CCM's share price has been volatile over the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: CCM underperformed the US Healthcare industry which returned 22.2% over the past year.
Return vs Market: CCM underperformed the US Market which returned 9.9% over the past year.
Price Volatility Vs. Market
How volatile is Concord Medical Services Holdings's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 month ago | Simply Wall StCan We See Significant Insider Ownership On The Concord Medical Services Holdings Limited (NYSE:CCM) Share Register?
3 months ago | Simply Wall StWhen Will Concord Medical Services Holdings Limited (NYSE:CCM) Turn A Profit?
5 months ago | Simply Wall StWhat Kind Of Shareholder Appears On The Concord Medical Services Holdings Limited's (NYSE:CCM) Shareholder Register?
Is Concord Medical Services Holdings undervalued compared to its fair value and its price relative to the market?
In this section, we usually try to help investors determine whether Concord Medical Services Holdings is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Concord Medical Services Holdings has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.
This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.
- Take a look at our analysis of CCM’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
- When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through Concord Medical Services Holdings regulatory filings.
- Explore potentially undervalued companies in the Healthcare industry.
How is Concord Medical Services Holdings forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CCM is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: CCM is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: CCM is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: CCM's revenue (16.1% per year) is forecast to grow faster than the US market (8.8% per year).
High Growth Revenue: CCM's revenue (16.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CCM is forecast to be unprofitable in 3 years.
How has Concord Medical Services Holdings performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CCM is currently unprofitable.
Growing Profit Margin: CCM is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: CCM is unprofitable, and losses have increased over the past 5 years at a rate of -42.2% per year.
Accelerating Growth: Unable to compare CCM's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CCM is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (10.5%).
Return on Equity
High ROE: CCM has a negative Return on Equity (-18.64%), as it is currently unprofitable.
How is Concord Medical Services Holdings's financial position?
Financial Position Analysis
Short Term Liabilities: CCM's short term assets (CN¥282.5M) do not cover its short term liabilities (CN¥627.5M).
Long Term Liabilities: CCM's short term assets (CN¥282.5M) do not cover its long term liabilities (CN¥1.8B).
Debt to Equity History and Analysis
Debt Level: CCM's debt to equity ratio (85.8%) is considered high.
Reducing Debt: CCM's debt to equity ratio has increased from 47.5% to 85.8% over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CCM has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: CCM has less than a year of cash runway if free cash flow continues to reduce at historical rates of 43.8% each year
What is Concord Medical Services Holdings's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate CCM's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate CCM's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if CCM's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if CCM's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: CCM is not paying a notable dividend for the US market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of CCM's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Jianyu Yang (48yo)
Dr. Jianyu Yang has been the Chief Executive Officer at Concord Medical Services Holdings Limited since 2008 and served as its President from 2008 to November 27, 2011. Dr. Yang served as the Chief Executi ...
|Chairman & CEO||12.42yrs||no data||no data|
|CFO & President||1.25yrs||no data||0.98% CN¥589.0k|
|Chief Operating Officer||1.25yrs||no data||no data|
|Chief Medical Officer||1.25yrs||no data||no data|
|Financial Controller||8.58yrs||no data||no data|
Experienced Management: CCM's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.
|Chairman & CEO||12.42yrs||no data||no data|
|Independent Director||10.5yrs||no data||no data|
|Director||12.42yrs||no data||no data|
|Independent Director||8.58yrs||no data||no data|
|Independent Director||2.75yrs||no data||no data|
|Director||0.58yr||no data||no data|
Experienced Board: CCM's board of directors are considered experienced (8.6 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Concord Medical Services Holdings Limited's company bio, employee growth, exchange listings and data sources
- Name: Concord Medical Services Holdings Limited
- Ticker: CCM
- Exchange: NYSE
- Founded: 2007
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: US$60.345m
- Shares outstanding: 43.41m
- Website: https://www.concordmedical.com
Number of Employees
- Concord Medical Services Holdings Limited
- Tower A, Global Trade Center
- 18th Floor
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|CCM||NYSE (New York Stock Exchange)||Yes||ADS EACH 1 REPR 3 ORD SHS (USD0.0001)||US||USD||Dec 2009|
|C2CA||DB (Deutsche Boerse AG)||Yes||ADS EACH 1 REPR 3 ORD SHS (USD0.0001)||DE||EUR||Dec 2009|
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China. The company operates in Network and Hospital segments. The company’s services comprise linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, and diagnostic imaging services. It also offers other treatments and diagnostic services comprising electroencephalography for the diagnosis of epilepsy; thermotherapy for pain relief after radiotherapy and chemotherapy; ultrasound therapy for the treatment of cancer; stereotactic radiofrequency ablation for the treatment of Parkinson’s disease; and refraction and tonometry for the diagnosis of ophthalmic conditions. In addition, the company provides clinical support services, including developing treatment protocols for doctors; and organizing joint diagnosis between doctors in its network and clinical research. Further, it offers radiotherapy and diagnostic equipment leasing and management services to hospitals, as well as tele-consulting services; and sells medical equipment. Additionally, the company establishes the Beijing Proton Medical Center that provides radiotherapy treatment options to cancer patients; and other specialty cancer hospitals, which offer radiotherapy services, diagnostic imaging services, chemotherapy, and surgery. As of June 30, 2019, it operated a network of 30 centers based in 20 hospitals in 20 cities across 13 provinces and administrative regions in China. Concord Medical Services Holdings Limited was incorporated in 2007 and is headquartered in Beijing, the People’s Republic of China.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/06/01 04:24|
|End of Day Share Price||2020/05/29 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.